Download
https://www.ndtvprofit.com/markets/sun-pharma-is-top-nifty-gainer-as-analysts-remain-bullish-after-q2-results?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Of the 39 analysts tracking the Sun Pharma stock, 29 have a ‘buy’ rating, three suggest a ‘hold’ and rest recommend a ‘sell’.
Share